Boardroom trades July 26

Latest directors’ deals at Sinclair IS Pharma, Ixico, VP and Metal Tiger

GSK investigating Syrian charges

Whistleblower points to alleged bribes for use of drugs

Roche sales hit by strong Swiss franc

Diagnostics unit writedown weighs on pharmaceutical group

GSK stumbles in the final furlong

Advair drug disappoints as group heads into period of transition

GSK cuts guidance as profits slide

Battle to remain dominant in respiratory drugs

Allergan restructuring to cost 1,500 jobs

Botox maker steps up efforts to fight Valeant’s hostile bid

Investors turn sour on US biotech

Flight from sector amid worries over high valuations

Shire chief’s $10m ‘golden hello’

Other senior staff to share $23m in retention bonuses

Technology: Wear your medicine

New wearable digital devices could signal a radical shift in medical practice

Tax inversion risk threatened Shire talks

Target’s call for reverse break fee came amid political backdrop

AbbVie rounds on US tax laws over Shire

UK drug company recommends £32bn offer from US group

AstraZeneca unveils £330m R&D centre plan

Cambridge facility to house London HQ and Cheshire research staff

Aids experts among those on Malaysian jet

Up to 100 delegates of Aids conference may have been on the flight

Doctors to put up to 12m people on statins

Use of cholesterol-lowering drugs set to rise under Nice guidance

AbbVie set to unveil £31bn Shire takeover

Latest US group to buy foreign rival as way to lower its tax bill

China backtracks on GSK secret trial

Move to hold trial in public follows pressure from US and UK

Novartis maintains forecasts

Pharma group warns of exposure to generic competition in the US

Foreign companies easy targets in China

Targeting multinationals poses little risk but offers much in political gain

GSK admits to 2001 China bribery scandal

Eli Lilly in cancer drug tie-up

Deal with Immunocore to develop new era of treatments


More FT Twitter accounts